"When I started out in the ophthalmology business 20 years ago, you barely heard anything about macular degeneration, " says Neurotech Pharmaceuticals Chief Executive Edward Danse.
FORBES: Banishing Blind Spots
2.
Neurotech Pharmaceuticals is testing a tiny polymer capsule that is implanted in the back of the eye and continuously pumps out a nourishing protein for six months or longer.
FORBES: Banishing Blind Spots
3.
Whatever the answers, we are entering the neurotech era.